Forskolin decreases sensitivity of brain adenylate cyclase to inhibition by 2',5'-dideoxyadenosine.
The effects of forskolin on the sensitivity of adenylate cyclase to 'P'-site-mediated inhibition were studied. Stimulation of crude and purified preparations of adenylate cyclase by forskolin led to decreased sensitivity to inhibition by 2',5' dideoxyadenosine with enzyme from rat and bovine brain. This is in contrast with the enhancement of P-site sensitivity induced by calmodulin, divalent cations, and stable GTP analogs and is in contrast with behavior seen with enzyme from liver and S49 cyc membranes. The effect of forskolin on P-site sensitivity of the brain adenylate cyclase was not dependent on the presence of G-proteins or calmodulin. It was not the consequence of proteolysis nor was it due to an obvious artifact in the assay procedures. This distinct behavior of the brain enzyme is most likely due to a structural difference in the catalytic subunit.
Stübner
D
D
Department of Physiology and Biophysics, State University of New York, Stony Brook 11794-8661.
Johnson
R A
RA
D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D001921:Brain / Q000201:enzymology*; D002147:Calmodulin / Q000494:pharmacology; D002384:Catalysis; D005576:Colforsin / Q000494:pharmacology*; D016048:Dideoxyadenosine / Q000031:analogs & derivatives*; D015224:Dideoxynucleosides / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004347:Drug Interactions; D051381:Rats
D000067956:Adenylyl Cyclase Inhibitors; D002147:Calmodulin; D015224:Dideoxynucleosides; D005576:Colforsin; D016048:Dideoxyadenosine; C021008:2',5'-dideoxyadenosine